GRIFOLS | GRF - Cost Of Sales


GRIFOLS reported EUR1.17B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Alcon AG USD 1.18B 26M Mar/2026
Almirall EUR 199.26M 7.76M Jun/2026
Amadeus IT EUR 552M 37.5M Jun/2026
Amarin USD 26.05M 1.41M Dec/2025
argenx SE USD 145M 24M Jun/2026
AstraZeneca USD 2.52B 2.73B Jun/2026
Bayer EUR 5.23B 731M Mar/2026
Cie Automotive EUR 1.21B 19.7M Dec/2025
Demant DKK 2.89B 188M Dec/2025
Ence Energia y Celulosa EUR 89.8M 19.53M Mar/2026
Essilor EUR 5.55B 505M Jun/2026
Ferrovial EUR 1.77B 906M Jun/2026
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Genmab DKK 84M 19M Jun/2026
GlaxoSmithKline GBP 2.07B 192M Jun/2026
GRIFOLS EUR 1.17B 90M Jun/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Inditex EUR 4.2B 1.99B Mar/2026
Lakefront Biotherapeutics EUR 4.8M 4.34M Mar/2026
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.71B 251M Jun/2026
Philips EUR 2.21B 70M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
Smith & Nephew USD 901M 31M Jun/2026
UCB EUR 1.07B 146M Dec/2025
Viscofan EUR 205.04M 12.56M Jun/2026